ProfileGDS4095 / 210819_x_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 3% 8% 7% 10% 5% 9% 8% 10% 12% 6% 9% 13% 20% 16% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep11.504123
GSM709769LY2 SRC1-siRNA tamoxifen treated rep31.70178
GSM709765LY2 SRC1-siRNA untreated rep31.689937
GSM709771LY2 SRC1-siRNA untreated rep11.7528810
GSM709772LY2 SRC1-siRNA untreated rep21.600695
GSM709775LY2 SRC1-siRNA untreated rep41.739399
GSM709764LY2 control-siRNA tamoxifen treated rep21.718048
GSM709766LY2 control-siRNA tamoxifen treated rep31.757710
GSM709768LY2 control-siRNA tamoxifen treated rep11.8041812
GSM709777LY2 control-siRNA tamoxifen treated rep41.639496
GSM709770LY2 control-siRNA untreated rep31.716269
GSM709773LY2 control-siRNA untreated rep11.8390413
GSM709774LY2 control-siRNA untreated rep22.0515220
GSM709776LY2 control-siRNA untreated rep41.9093116